抗血小板药物在缺血性脑卒中的应用进展

被引:3
作者
王潜
机构
[1] 上海市第九人民医院神经内科
关键词
抗血小板药物; 脑卒中; 预防; 进展;
D O I
10.16440/j.cnki.1674-8166.2014.01.010
中图分类号
R743.3 [急性脑血管疾病(中风)];
学科分类号
1002 ;
摘要
在我国老龄化趋势日益加速的情况下,脑卒中的危害日益突出,对脑卒中的预防已经成为卫生工作的重要课题之一,也越来越引起国内外医学界特别是神经科学界的重视,而抗血小板药物是预防脑卒中的重要手段之一。本文对抗血小板药物在缺血性脑卒中的应用进展进行综述。
引用
收藏
页码:63 / 65
页数:3
相关论文
共 15 条
[1]   《急性缺血性脑血管病中西医诊疗指南》解读 [J].
陈怀珍 .
中医药临床杂志, 2013, 25 (11) :949-954
[3]   扩大时间窗溶栓:急性卒中治疗13年来最大的进步——欧洲协作性急性卒中研究-3(ECASS3)结果解读 [J].
李焰生 .
中国卒中杂志, 2009, 4 (01) :13-18
[4]  
缺血性脑卒中的临床及预后分析[D]. 刘福贤.吉林大学. 2005
[5]  
Sarpogrelate-Aspirin Comparative Clinical Study for Efficacy and Safety in Secondary Prevention of Cerebral Infarction (S-ACCESS): A Randomized, Double-Blind, Aspirin-Controlled Trial[J] . Yukito Shinohara,Katsuya Nishimaru,Tohru Sawada,Akiro Terashi,Shunnosuke Handa,Shunsaku Hirai,Kunihiko Hayashi,Hideo Tohgi,Yasuo Fukuuchi,Shinichiro Uchiyama,Takenori Yamaguchi,Shotai Kobayashi,Kazuoki Kondo,Eiichi Otomo,Fumio Gotoh. Stroke . 2008 (6)
[6]   Trends in usage of alternative antiplatelet therapy after stroke and transient ischemic attack [J].
Hills, Nancy K. ;
Johnston, S. Claiborne .
STROKE, 2008, 39 (04) :1228-1232
[7]  
Patients With Prior Myocardial Infarction, Stroke, or Symptomatic Peripheral Arterial Disease in the CHARISMA Trial[J] . Deepak L. Bhatt,Marcus D. Flather,Werner Hacke,Peter B. Berger,Henry R. Black,William E. Boden,Patrice Cacoub,Eric A. Cohen,Mark A. Creager,J. Donald Easton,Christian W. Hamm,Graeme J. Hankey,S. Claiborne Johnston,Koon-Hou Mak,Jean-Louis Mas,Gilles Montalescot,Thomas A. Pearson,P. Gabriel Steg,Steven R. Steinhubl,Michael A. Weber,Liz Fabry-Ribaudo,Tingfei Hu,Eric J. Topo
[8]   Aspirin resistance [J].
Hankey, GJ ;
Eikelboom, J .
LANCET, 2006, 367 (9510) :606-617
[9]  
Cilostazol Prevents the Progression of the Symptomatic Intracranial Arterial Stenosis: The Multicenter Double-Blind Placebo-Controlled Trial of Cilostazol in Symptomatic Intracranial Arterial Stenosis[J] . Sun U. Kwon,Yong-Jin Cho,Ja-Seong Koo,Hee-Joon Bae,Yong-Seok Lee,Keun-Sik Hong,Jun Hong Lee,Jong S. Kim. Stroke . 2005 (4)
[10]  
Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial[J] . Hans-Christoph Diener,Julien Bogousslavsky,Lawrence M Brass,Claudio Cimminiello,Laszlo Csiba,Markku Kaste,Didier Leys,Jordi Matias-Guiu,Hans-Jürgen Rupprecht. The Lancet . 2004 (9431)